Preliminary Final Report
Filed with ASX · · 1 page · English
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Becoming a substantial holder
- Ceasing to be a substantial holder
- Change in substantial holding
- Change of Director Interest Notice - R Basser
- Change of Director Interest Notice - R Thomas
Later from Starpharma
- 2026 Annual Report
- 2026 Appendix 4G and Corporate Governance Statement
- FY26 Key Financial Results and Annual Report
- S&P DJI Announces September 2026 Quarterly Rebalance
- Annual General Meeting 2026 Date
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma